Clinical Trial Update: Safety of Maraviroc for Post-stroke Depression [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating safety of maraviroc for post-stroke depression has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Post-stroke Depression

Drugs mentioned

• Maraviroc (maraviroc)

Snippet

Sponsor: Tel-Aviv Sourasky Medical Center | Conditions: Post-stroke Depression | Phase 2 | Status: COMPLETED